Pharma Journalist -

Surefire Medical affirmed the appointment of Mary T. Szela as its CEO, President and a member of the company's Board Of Directors. James Chomas PhD precedes Szela who served as…
Read More...

JSR life sciences of the JSR corporation confirmed the appointment of Dr. Nalini Murdter as the President and Chief Executive Officer of MBL International with effect immediately.…
Read More...

Puma Biotechnology asserted that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has conveyed a negative trend vote after discussions…
Read More...

Cerus Corporation asserted successful achievement of primary efficacy and safety endpoints in the Company's Phase 3 transfusion study of Chronic anaemia assessing INTERCEPT-treated Red…
Read More...

One of the leading pharmaceutical companies in the Middle East and North Africa region, Tabuk Pharmaceuticals enters into licensing and supply agreement with red otc development GmbH on…
Read More...

Alexion Pharmaceuticals, confirmed that Deborah Dunsire, MD has been appointed to its Board of Directors as a new independent director. Dr. Dunsire served as President and Chief…
Read More...

Celgene Corporation and Juno Therapeutics signed a definitive merger agreement in which Celgene has initiated acquisition of Juno Therapeutics. As per the terms of the agreement, …
Read More...

Seattle Genetics confirmed that its collaborator, Takeda Pharmaceutical Company Limited has asserted the fact that European Commission has extended the current conditional marketing…
Read More...

In order to offer a robust, and economically viable solution for anatomical pathology, Enzo Biochem asserted the authentication of a cervical Cancer biomarker detection test offering a…
Read More...

Baxter asserted the approval of U.S. Food and Drug Administration for Bivalirudin in 0.9 percent Sodium Chloride Injection (bivalirudin). Baxter's premixed medications are manufactured…
Read More...